Cargando…
On the Added Value of Baseline FDG-PET in Malignant Lymphoma
PURPOSE: The added value of baseline positron emission tomography (PET) scans in therapy evaluation in malignant lymphoma is unclear. In guidelines, baseline PET is recommended but not mandatory except in lymphoma types with variable fluoro-d-glucose uptake. The aim of the present study was to test...
Autores principales: | Quarles van Ufford, Henriette, Hoekstra, Otto, de Haas, Marie, Fijnheer, Rob, Wittebol, Shulamiet, Tieks, Bianca, Kramer, Mark, de Klerk, John |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844531/ https://www.ncbi.nlm.nih.gov/pubmed/19809855 http://dx.doi.org/10.1007/s11307-009-0259-3 |
Ejemplares similares
-
(18)F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma
por: Eertink, Jakoba J., et al.
Publicado: (2021) -
Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma
por: Nievelstein, R. A. J., et al.
Publicado: (2012) -
FDG-PET in lymphoma
por: Meignan, Michel
Publicado: (2014) -
Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients
por: Weisman, Amy J., et al.
Publicado: (2020) -
Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020)